Self-monitoring Blood Glucose (SMBG): Now and the Future
- 1 February 2004
- journal article
- Published by SAGE Publications in Journal of Pharmacy Practice
- Vol. 17 (1), 29-38
- https://doi.org/10.1177/0897190003261306
Abstract
In 2002, the cost of diabetes in the United States reached $132 billion. There is a well-established relationship between blood glucose control and the risk of diabetes-related complications. Tight blood glucose control, through intensive diabetes therapy, reduces the risk and delays the onset of diabetesrelated microvascular complications. Regular and consistent self-monitoring of blood glucose (SMBG) is and should be a part of all diabetes disease state management programs. Pharmacists can truly increase the numbers of patients who use SMBG by being aware and familiar with the monitoring devices available to patients and identifying the physical and psychological issues surrounding SMBG. Results from SMBG and hemoglobin A1C are the basis formost of the medical decisions made for patients with diabetes. This review discusses the best time for patients to test their blood glucose, information regarding blood glucose monitoring devices, alternative site testing, and the newest technology available in glucose monitoring.Keywords
This publication has 29 references indexed in Scilit:
- Tests of Glycemia in DiabetesDiabetes Care, 2003
- Report of the Expert Committee on the Diagnosis and Classification of Diabetes MellitusDiabetes Care, 2003
- Standards of Medical Care for Patients With Diabetes MellitusDiabetes Care, 2003
- The Impact of Blood Glucose Self-Monitoring on Metabolic Control and Quality of Life in Type 2 Diabetic PatientsDiabetes Care, 2001
- Response to Jungheim and KoschinskyDiabetes Care, 2001
- Frequency of Blood Glucose Monitoring in Relation to Glycemic Control in Patients With Type 2 DiabetesDiabetes Care, 2001
- Continuous Subcutaneous Glucose Monitoring in Children With Type 1 DiabetesPublished by American Academy of Pediatrics (AAP) ,2001
- Diabetes Care Practices in Primary Care: Results from Two Samples and Three Measurement SetsThe Diabetes Educator, 1999
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Phobic Symptoms, Particularly the Fear of Blood and Injury, Are Associated With Poor Glycemic Control in Type I Diabetic AdultsDiabetes Care, 1997